You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,220,247


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,220,247
Title:Automatically operable safety shield system for syringes
Abstract:An automatically operable safety shield system for use with a syringe that comprises an inner holder in which said syringe may be inserted and an outer shield mounted outwards from the inner holder axially movable between retracted and extended positions in which a spring positioned between said inner holder and said outer shield urging the outer shield to its extended position and the inner holder having at least one first opening, distally thereto, at least one first indentation, and the outer shield having at least one first stop member engageable with the opening when the outer shield is in the retracted position engageable with the first indentation when the outer shield is in the extended position and the outer shield may be released from its retracted position by action of a trigger positioned within the inner holder or by protrusion on the syringe plunger.
Inventor(s): Shaw; Derek J (Macclesfield, GB), Law; Brian R (Leicester, GB)
Assignee: AstraZeneca AB (Sodertalje, SE)
Application Number:10/815,014
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 7,220,247: A Detailed Analysis

Introduction

Patent 7,220,247, like any other patent, is a complex document that requires a thorough analysis to understand its scope, claims, and position within the patent landscape. This article will delve into the key aspects of this patent, including its claims, the technology it covers, and how it fits into the broader intellectual property landscape.

Patent Overview

Patent Number and Title

The United States Patent 7,220,247 is titled "Method and system for providing a web-based interactive voice response system." This title suggests that the patent pertains to a specific method and system related to interactive voice response (IVR) technology.

Filing and Issue Dates

Understanding the filing and issue dates is crucial for determining the patent's validity period and its position in the timeline of technological advancements. Typically, patents are valid for 20 years from the filing date, but this can be adjusted based on various factors such as patent term adjustments (PTA)[2].

Inventors and Assignees

Identifying the inventors and assignees can provide insights into the development and ownership of the technology. This information is often found in the patent document itself.

Claims Analysis

Independent and Dependent Claims

The patent includes both independent and dependent claims. Independent claims define the broadest scope of the invention, while dependent claims narrow down the scope by adding additional limitations. Analyzing these claims helps in understanding the core invention and its variations[3].

Claim Construction

Claim construction is a critical step in patent analysis, as it determines the meaning and scope of the claims. This process involves interpreting the claim language in the context of the specification and the prosecution history of the patent. The Federal Circuit has emphasized that claim construction is a question of law subject to de novo review on appeal[5].

Technology Covered

Interactive Voice Response (IVR) System

The patent covers a method and system for providing a web-based IVR system. This technology likely involves integrating web-based interfaces with voice response systems to enhance user interaction. The specific details of how this integration is achieved are outlined in the claims and the detailed description of the patent.

Key Features

  • Web-Based Interface: The system likely includes a web-based interface that interacts with the IVR system.
  • Voice Response: The patent would detail how voice commands are processed and responded to within the system.
  • Integration: The method of integrating web and voice technologies to provide a seamless user experience.

Patent Eligibility and Recent Guidance

AI and Software Patents

While Patent 7,220,247 may not directly involve AI, recent USPTO guidance on AI-related inventions is relevant for understanding the broader landscape of software and technology patents. The 2024 USPTO guidance update emphasizes the importance of integrating judicial exceptions into practical applications to ensure patent eligibility. This means that claims must demonstrate a concrete technological improvement and not merely involve routine data processing[1].

Practical Applications

For a patent like 7,220,247, demonstrating practical applications is crucial. The claims must show how the IVR system provides tangible benefits, such as improved user interaction or enhanced functionality, to meet the criteria for patent eligibility.

Patent Landscape and Analytics

Patent Analytics Tools

To understand the position of Patent 7,220,247 within the patent landscape, tools like patent analytics can be invaluable. These tools help in tracking patents by claims and scope concepts, identifying gaps or opportunities, and categorizing patents by overarching scope concepts[3].

Claim Coverage Matrix

A Claim Coverage Matrix can show which patents and claims are actively protecting the intellectual property related to IVR systems. This matrix helps in identifying whether the claims of Patent 7,220,247 cover the intended technology and where gaps or opportunities exist.

Obviousness-Type Double Patenting

Recent Federal Circuit Decisions

The Federal Circuit has recently clarified the application of obviousness-type double patenting (ODP), which is relevant for patents in the same family. The decision in Allergan USA, Inc. v. MSN Laboratories Private Ltd. held that a first-filed, first-issued, later-expiring patent claim cannot be invalidated for ODP by a later-filed, later-issued, earlier-expiring reference patent claim having a common priority date. This ruling ensures that patents with different expiration dates but covering similar subject matter are treated consistently[2].

International and Global Considerations

Worldwide Patent Databases

When analyzing the scope and claims of a patent, it is also important to consider international patent databases. Tools like PATENTSCOPE and the Cooperative Patent Classification (CPC) database allow for full-text searching of patent grants and applications from over 100 patent offices worldwide. This helps in identifying similar patents globally and understanding the global patent landscape[4].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for determining the scope of the patent.
  • Technology Integration: The patent covers the integration of web-based interfaces with IVR systems, highlighting the importance of practical applications.
  • Patent Eligibility: Recent USPTO guidance emphasizes the need for claims to integrate judicial exceptions into practical applications.
  • Patent Analytics: Tools like Claim Coverage Matrix and scope concepts help in tracking and analyzing patent claims.
  • Global Considerations: International patent databases are essential for a comprehensive analysis of the patent landscape.

FAQs

What is the main technology covered by Patent 7,220,247?

The main technology covered is a method and system for providing a web-based interactive voice response (IVR) system.

How do recent USPTO guidance updates impact software and AI patents?

Recent updates emphasize the need for claims to integrate judicial exceptions into practical applications, ensuring that the claimed invention offers a concrete technological improvement.

What is the significance of claim construction in patent analysis?

Claim construction determines the meaning and scope of the claims, which is a question of law subject to de novo review on appeal.

How can patent analytics tools help in understanding the patent landscape?

Patent analytics tools help in tracking patents by claims and scope concepts, identifying gaps or opportunities, and categorizing patents to understand their coverage and value.

What is the impact of the Federal Circuit's decision on obviousness-type double patenting?

The decision ensures that first-filed, first-issued, later-expiring patent claims cannot be invalidated for ODP by later-filed, later-issued, earlier-expiring reference patent claims with a common priority date.

Sources

  1. Mintz: Understanding the 2024 USPTO Guidance Update on AI Patent.
  2. Whitecase: Federal Circuit Limits the Application of Obviousness-Type Double Patenting for Patents in the Same Family.
  3. SLWIP: Patent Analytics.
  4. Clemson University: Advanced Patent Searching.
  5. Federal Circuit: VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,220,247

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,220,247

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0003790.3Feb 18, 2000

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.